These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 23733037)

  • 1. Determining the validity of hospital laboratory reference intervals for healthy young adults participating in early clinical trials of candidate vaccines.
    Rowland R; O'Hara GA; Hamill M; Poulton ID; Donaldson H; Dinsmore L; James T; Barnes E; Klenerman P; Gilbert SC; Hill AV; Shine B; McShane H
    Hum Vaccin Immunother; 2013 Aug; 9(8):1741-51. PubMed ID: 23733037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa.
    Karita E; Ketter N; Price MA; Kayitenkore K; Kaleebu P; Nanvubya A; Anzala O; Jaoko W; Mutua G; Ruzagira E; Mulenga J; Sanders EJ; Mwangome M; Allen S; Bwanika A; Bahemuka U; Awuondo K; Omosa G; Farah B; Amornkul P; Birungi J; Yates S; Stoll-Johnson L; Gilmour J; Stevens G; Shutes E; Manigart O; Hughes P; Dally L; Scott J; Stevens W; Fast P; Kamali A
    PLoS One; 2009; 4(2):e4401. PubMed ID: 19197365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reference intervals in healthy adult Ugandan blood donors and their impact on conducting international vaccine trials.
    Eller LA; Eller MA; Ouma B; Kataaha P; Kyabaggu D; Tumusiime R; Wandege J; Sanya R; Sateren WB; Wabwire-Mangen F; Kibuuka H; Robb ML; Michael NL; de Souza MS
    PLoS One; 2008; 3(12):e3919. PubMed ID: 19079547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haematological and biochemistry laboratory abnormalities associated with splenomegaly in asymptomatic adults in Masaka, Uganda: implications for HIV biomedical prevention trials.
    Ruzagira E; Abaasa A; Levin J; Bahemuka U; Bwanika A; Amornkul PN; Price MA; Grosskurth H; Kamali A
    Trop Med Int Health; 2010 Jan; 15(1):105-12. PubMed ID: 19968840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of Haematological Reference Ranges in Healthy Adults in Three Regions in Ghana.
    Addai-Mensah O; Gyamfi D; Duneeh RV; Danquah KO; Annani-Akollor ME; Boateng L; Owiredu EW; Amponsah FA; Afriyie EY; Asare R; Ofosu DN
    Biomed Res Int; 2019; 2019():7467512. PubMed ID: 30868073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of safety in newborns of mothers participating in clinical trials of vaccines administered during pregnancy.
    Munoz FM; Weisman LE; Read JS; Siberry G; Kotloff K; Friedman J; Higgins RD; Hill H; Seifert H; Nesin M
    Clin Infect Dis; 2014 Dec; 59 Suppl 7(Suppl 7):S415-27. PubMed ID: 25425720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The selection of healthy volunteers for clinical investigation: the case for volunteer pools.
    Joubert P; Pannall P
    Curr Med Res Opin; 1976; 4(3):192-6. PubMed ID: 780060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of locally established reference intervals for hematology and biochemistry parameters in Western Kenya.
    Odhiambo C; Oyaro B; Odipo R; Otieno F; Alemnji G; Williamson J; Zeh C
    PLoS One; 2015; 10(4):e0123140. PubMed ID: 25874714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The UPTAKE study: implications for the future of COVID-19 vaccination trial recruitment in UK and beyond.
    Sethi S; Kumar A; Mandal A; Shaikh M; Hall CA; Kirk JMW; Moss P; Brookes MJ; Basu S
    Trials; 2021 Apr; 22(1):296. PubMed ID: 33879208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reference intervals of common clinical biochemistry analytes in young Nigerian adults.
    Ayemoba O; Okeji N; Hussain N; Umar T; Ajemba-Life A; Kene T; Edom U; Ogueri I; Nwagbara G; Ochai I; Adekanye U; Onoh I
    PLoS One; 2021; 16(3):e0247672. PubMed ID: 33647019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Needle size for vaccination procedures in children and adolescents.
    Beirne PV; Hennessy S; Cadogan SL; Shiely F; Fitzgerald T; MacLeod F
    Cochrane Database Syst Rev; 2015 Jun; (6):CD010720. PubMed ID: 26086647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutropenia as an Adverse Event following Vaccination: Results from Randomized Clinical Trials in Healthy Adults and Systematic Review.
    Muturi-Kioi V; Lewis D; Launay O; Leroux-Roels G; Anemona A; Loulergue P; Bodinham CL; Aerssens A; Groth N; Saul A; Podda A
    PLoS One; 2016; 11(8):e0157385. PubMed ID: 27490698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SENIORLAB: a prospective observational study investigating laboratory parameters and their reference intervals in the elderly.
    Risch M; Nydegger U; Risch L
    Medicine (Baltimore); 2017 Jan; 96(1):e5726. PubMed ID: 28072712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term safety and vaccine-induced seropositivity in healthy volunteers from HIV vaccine trials.
    Durier C; Desaint C; Lelièvre JD; Silbermann B; Pialoux G; Cuzin L; Bonnet B; Poizot-Martin I; Bouakane A; Paul C; Grabar S; Spire B; Meyer L; Launay O;
    AIDS; 2019 Nov; 33(13):2061-2071. PubMed ID: 31306171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surveillance for safety after immunization: Vaccine Adverse Event Reporting System (VAERS)--United States, 1991-2001.
    Zhou W; Pool V; Iskander JK; English-Bullard R; Ball R; Wise RP; Haber P; Pless RP; Mootrey G; Ellenberg SS; Braun MM; Chen RT
    MMWR Surveill Summ; 2003 Jan; 52(1):1-24. PubMed ID: 12825543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haematological and biochemical reference values for healthy adults in the middle belt of Ghana.
    Dosoo DK; Kayan K; Adu-Gyasi D; Kwara E; Ocran J; Osei-Kwakye K; Mahama E; Amenga-Etego S; Bilson P; Asante KP; Koram KA; Owusu-Agyei S
    PLoS One; 2012; 7(4):e36308. PubMed ID: 22558429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective influenza vaccines for children: a critical unmet medical need and a public health priority.
    Banzhoff A; Stoddard JJ
    Hum Vaccin Immunother; 2012 Mar; 8(3):398-402. PubMed ID: 22327501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How healthy are the "Healthy volunteers"? Penetrance of NAFLD in the biomedical research volunteer pool.
    Takyar V; Nath A; Beri A; Gharib AM; Rotman Y
    Hepatology; 2017 Sep; 66(3):825-833. PubMed ID: 28470683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods in vaccine effectiveness and safety studies: a critical need for vaccine confidence.
    Jacobsen SJ; Poland GA
    Vaccine; 2011 Dec; 29(52):9573-4. PubMed ID: 22051135
    [No Abstract]   [Full Text] [Related]  

  • 20. Schistosomiasis vaccine candidate Sm14/GLA-SE: Phase 1 safety and immunogenicity clinical trial in healthy, male adults.
    Santini-Oliveira M; Coler RN; Parra J; Veloso V; Jayashankar L; Pinto PM; Ciol MA; Bergquist R; Reed SG; Tendler M
    Vaccine; 2016 Jan; 34(4):586-594. PubMed ID: 26571311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.